Thomas Lemmin

Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G

Guillaume B. E. Stewart-Jones, Cinque Soto, Thomas Lemmin et al. · Cell · 2016 · 441 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

Rui Kong, Kai Xu, Tongqing Zhou et al. · Science · 2016 · 377 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

Kai Xu, Priyamvada Acharya, Rui Kong et al. · Nature Medicine · 2018 · 310 citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

Tongqing Zhou, Nicole A. Doria‐Rose, Cheng Cheng et al. · Cell Reports · 2017 · 196 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

Jason Gorman, Cinque Soto, Max M. Yang et al. · Nature Structural & Molecular Biology · 2015 · 195 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14